Side-by-side comparison of AI visibility scores, market position, and capabilities
Falls Church stealth defense systems (NYSE: NOC) ~$41B revenue; B-21 Raider stealth bomber (operational 2024), Sentinel ICBM, $1.4B IBCS air defense contracts for US Army and Poland competing with Lockheed Martin.
Northrop Grumman Corporation is a Falls Church, Virginia-based global aerospace and defense technology company — publicly traded on the New York Stock Exchange (NYSE: NOC) as an S&P 500 Industrials component — designing, developing, producing, and maintaining advanced defense systems including stealth combat aircraft, space systems, ground-based strategic nuclear weapons, battle management systems, and unmanned systems through approximately 95,000 employees worldwide. In fiscal year 2024, Northrop Grumman reported revenue of approximately $41 billion, with defense spending tailwinds from NATO alliance expansion, Indo-Pacific military modernization, and US Air Force strategic deterrence modernization. Northrop Grumman secured $1.4 billion in contracts to advance the Integrated Battle Command System (IBCS) — a next-generation air and missile defense battle management system for the US Army and Poland, connecting disparate sensors (radar, sonar, space-based sensors) and effectors (Patriot batteries, short-range air defense missiles) through a unified software-defined kill chain. CEO Kathy Warden — the first female CEO of a major US defense contractor — leads Northrop's strategy of focusing on the highest-technology defense programs where integration complexity creates durable sole-source competitive positions. The B-21 Raider stealth strategic bomber (the first new US strategic bomber in 35 years, beginning operational deliveries in 2024) is Northrop's defining program — a next-generation nuclear-capable stealth aircraft intended to replace the B-2 Spirit and eventually the B-1 Lancer through the late 2030s.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.